已收盘 05-08 16:00:00 美东时间
+0.935
+1.32%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Baird analyst David Rescott maintains LivaNova (NASDAQ:LIVN) with a Outperform and lowers the price target from $78 to $76.
05-07 19:41
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
华盛资讯5月7日讯,LivaNova Plc公布2026财年Q1业绩,公司Q1营收3.62亿美元,同比增长14.3%,归母净利润0.22亿美元,扭亏为盈。
05-07 01:16
LivaNova shares are trading higher after the company reported better-than-expec...
05-07 00:52
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised guidance. Other gaining stocks include EVC, BLMN, MNKD, FLEX, HUT, AVTX, COMP, VCYT, and SSRM.
05-06 22:39
LivaNova (NASDAQ:LIVN) held its first-quarter earnings conference call on Wedne...
05-06 21:07
华盛资讯5月6日讯,LivaNova Plc公布2026财年Q1业绩,公司Q1营收3.62亿美元,同比增长14.3%,归母净利润0.22亿美元,扭亏为盈。
05-06 20:54
Full-Year 2026 GuidanceLivaNova now expects full-year 2026 revenue to grow between 7.0% and 8.0% (versus 6.0% and 7.0% prior) on a constant-currency basis. Foreign currency is expected to be a tailwind of approximately
05-06 18:19
Full-Year 2026 GuidanceLivaNova now expects full-year 2026 revenue to grow between 7.0% and 8.0% (versus 6.0% and 7.0% prior) on a constant-currency basis. Foreign currency is expected to be a tailwind of approximately
05-06 18:06